Ondansetron Tablet, Orally Disintegrating
Product Images NDC 55154-3680

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-3680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron HCl Structural Formula (Image 01)

This is the description for Ondansetron Orally Disintegrating Tablets, a medication that helps to treat nausea and vomiting after surgery, chemotherapy, or radiation. Each tablet contains 4 mg of ondansetron and the medication meets USP Dissolution Test 2. The tablets should be stored at room temperature and should not be removed from the blister pack until ready for use. The medication is manufactured by Glenmark Pharmaceuticals and distributed by Cardinal Health. The label warns that the unit dose package is not child-resistant and is intended only for institutional use.*

FDA Label Image

Logo

FDA Label Image

Structure Base

FDA Label Image

Structure HCl

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.